UAB genetic scientists are engaged in robust preclinical research initiatives focused on testing the effectiveness of potential new drug therapies for NF1. These efforts utilize two primary approaches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback